Cat. #160582
OS-PT conjugate small molecule (tool compound)
Cat. #: 160582
Availability: Please enquire for quantities and pricing
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Czeslaw Lugowski ; Tomasz Niedziela ; Sabina Koj
Institute: Polish Center for Technology Development/Polski OĹrodek Rozwoju Technologii (PORT)
Tool Details
*FOR RESEARCH USE ONLY
- Tool name: OS-PT conjugate small molecule (tool compound)
- Description: Adapted from WO2014/195881 Bordetella pertussis causes whooping cough, a highly contagious disease involving the respiratory tract, which is especially serious for infants and young children. Despite widespread immunization, in recent years the number of pertussis incidences has increased. The limited efficacy of currently used pertussis vaccines results from the fact that their components do not induce a complete immune response. Unlike tetanus and diphtheria diseases where all symptoms are ...
- Additional notes: Adapted from WO2014/195881 This is a glycoconjugate of the complete dodecasaccharide derived from Bordetella pertussis LOS conjugated to a pertussis toxin which provides a vaccine component that is both immunogenic and non-toxic. It is a candidate for use in the pertussis vaccine composition as it constitutes a nontoxic and immunogenic combination of the two components of B. pertussis and thus generates optimal anti-pertussis response.
Handling
- Storage conditions: 4° C with the addition of a preservative (0,01 % merthiolate)
Related Tools
- Related tools: Penta-PT conjugate small molecule (tool compound)
References
- WO2014195881 - BORDETELLA PERTUSSIS LOS-DERIVED OLIGOSACCHARIDE WITH PERTUSSIS TOXIN GLYCOCONJUGATE AND ITS APPLICATION IN THE PROPHYLAXIS AND TREATMENT OF INFECTIONS CAUSED BY BORDETELLA PERTUSSIS
